Opko Health Inc. (OPK) Receives Hold Rating from Jefferies Group
Opko Health Inc. (NYSE:OPK)‘s stock had its “hold” rating reaffirmed by investment analysts at Jefferies Group in a research note issued to investors on Monday. They currently have a $10.00 price target on the stock. Jefferies Group’s price objective would suggest a potential upside of 0.91% from the stock’s current price.
A number of other research analysts have also issued reports on OPK. Oppenheimer Holdings Inc. reaffirmed a “market perform” rating on shares of Opko Health in a report on Thursday, August 11th. Zacks Investment Research cut Opko Health from a “hold” rating to a “sell” rating in a research note on Friday, July 1st. Standpoint Research lifted their price target on Opko Health from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, June 21st. Deutsche Bank AG dropped their price target on Opko Health from $11.00 to $10.00 and set a “hold” rating on the stock in a research note on Thursday, June 16th. Finally, JPMorgan Chase & Co. set a $14.00 price target on Opko Health and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Five analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Opko Health presently has a consensus rating of “Buy” and an average target price of $13.20.
Shares of Opko Health (NYSE:OPK) traded up 0.91% on Monday, hitting $10.00. 1,114,215 shares of the stock traded hands. The company’s 50 day moving average is $10.06 and its 200 day moving average is $10.12. The stock has a market cap of $5.50 billion and a price-to-earnings ratio of 41.84. Opko Health has a one year low of $7.12 and a one year high of $11.85.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/10/opko-health-inc-opk-receives-hold-rating-from-jefferies-group.html
Opko Health (NYSE:OPK) last released its earnings results on Monday, August 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.05. The firm had revenue of $357.10 million for the quarter, compared to analyst estimates of $324.11 million. Opko Health’s revenue was up 742.2% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.09) earnings per share. On average, equities analysts forecast that Opko Health will post ($0.05) EPS for the current year.
In other news, CEO Phillip Md Et Al Frost purchased 3,600 shares of Opko Health stock in a transaction dated Friday, September 9th. The stock was acquired at an average cost of $9.87 per share, for a total transaction of $35,532.00. Following the acquisition, the chief executive officer now directly owns 3,068,951 shares in the company, valued at $30,290,546.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Several large investors have recently made changes to their positions in OPK. Bridger Management LLC purchased a new stake in shares of Opko Health during the first quarter valued at about $13,863,000. Amici Capital LLC purchased a new stake in shares of Opko Health during the first quarter valued at about $842,000. Schonfeld Strategic Advisors LLC purchased a new stake in shares of Opko Health during the first quarter valued at about $141,000. LGL Partners LLC purchased a new stake in shares of Opko Health during the first quarter valued at about $556,000. Finally, Geode Capital Management LLC raised its stake in shares of Opko Health by 6.6% in the first quarter. Geode Capital Management LLC now owns 1,923,455 shares of the company’s stock valued at $19,984,000 after buying an additional 118,512 shares in the last quarter.
Opko Health Company Profile
OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.
Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.